Endocrine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q3 | 50.5% | 0.983 | Q2 | 83.5% |
| 2024 | 2.9 | Q3 | 50.8% | 0.971 | Q2 | 83.4% |
| 2023 | 3.0 | Q2 | 53.1% | 0.844 | Q2 | 81.4% |
| 2022 | 3.7 | Q3 | 54.8% | 0.824 | Q2 | 81.3% |
| 2021 | 3.9 | Q3 | 57.4% | 0.873 | Q2 | 83.5% |
| 2020 | — | — | 1.002 | Q2 | 85.4% | |
| 2019 | — | — | 1.122 | Q2 | 88.0% | |
| 2018 | — | — | 1.087 | Q2 | 86.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1355-008X
ISSN
1559-0100
country
UScoverage
1993-2026